HIMS Shares Plunge As Pivot To Branded GLP-1s Weighs On Outlook
--------------------------------------------------------------------
Source: Zero Hedge
Published: 2026-05-12 21:45 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Business, Health, Drugs
--------------------------------------------------------------------
Snippet:
Hims & Hers shares tumbled in premarket trading in New York, the most in three months, after the company posted a first-quarter loss and revenue that missed analyst estimates tracked by Bloomberg, as costs rose amid a massive pivot from selling copycat GLP-1 drugs toward branded obesity drugs from Novo Nordisk and Eli Lilly.
--------------------------------------------------------------------